Long-Term Disease Control Of Advanced Gastrointestinal Stromal Tumors (Gist) With Imatinib (Im): 10-Year Outcomes From Swog Phase Iii Intergroup Trial S0033.

George D. Demetri,Cathryn J. Rankin,Robert S. Benjamin,Ernest C. Borden,Christopher W. Ryan,Dennis A. Priebat,William D. Tap,Margaret Von Mehren,Martin E. Blackstein,Michael C. Heinrich,Robert G. Maki,Christopher L. Corless,Jonathan A. Fletcher,Kouros Owzar,Charles David Blanke

JOURNAL OF CLINICAL ONCOLOGY（2014）

引用 15|浏览27

暂无评分

摘要

10508 Background: S0033 was designed to study the impact of IM, randomized between two doses, in patients (pts) with incurable GIST. Methods: Full accrual to this phase III trial occurred over 8 mo...

查看译文

关键词

advanced gastrointestinal stromal tumors,imatinib,gist,long-term

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要